文献速递心境障碍物质与行为成瘾

正念导向康复提升疗法对长期阿片治疗的退伍军人及军人慢性疼痛的随机临床试验

Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial.
PubMed 文献 · Am J Psychiatry · 2024-01-10

这项随机临床试验在230名长期使用阿片类药物治疗慢性疼痛的过去和现在美国军人中,比较正念导向康复提升疗法(MORE)与支持性心理治疗。结果显示MORE在8个月随访中更有效减轻疼痛相关功能干扰、疼痛严重度和阿片剂量,并减少快感缺失、疼痛灾难化、渴求和阿片线索注意偏差,增加积极情感。

要点

  • MORE在8个月随访中优于支持性心理治疗,减轻疼痛相关功能干扰和疼痛严重度。
  • MORE使每日阿片剂量减少20.7%,支持性心理治疗减少3.9%。
  • MORE减少快感缺失、疼痛灾难化、渴求和阿片注意偏差,增加积极情感。

核心结论

  • 在长期阿片治疗的慢性疼痛军人中,MORE带来慢性疼痛、阿片使用、渴求和阿片线索反应的持续下降。
  • MORE促进阿片剂量减少,同时维持充分疼痛控制并预防情绪障碍,提示其用于安全阿片减量的效用。

研究设计与样本

  • 随机临床试验,230名有长期阿片治疗处方的过去和现在美国军人按1:1随机分配至MORE或支持性心理治疗。
  • 干预初始面对面进行,COVID-19疫情后改为视频会议进行。
  • 主要结局为8个月随访期间用简明疼痛量表测量的慢性疼痛和用当前阿片滥用测量量表测量的异常药物相关行为。

主要发现

  • MORE在8个月随访中减少疼痛相关功能干扰、疼痛严重度和阿片剂量方面优于支持性心理治疗。
  • MORE使每日阿片剂量减少20.7%,支持性心理治疗减少3.9%。
  • 阿片滥用总体无组间差异,但面对面MORE在减少阿片滥用方面优于支持性心理治疗。
  • MORE更大程度减少快感缺失、疼痛灾难化、渴求和阿片注意偏差,并增加积极情感。
  • MORE调节治疗过程,包括对疼痛感受的正念重新解释、非反应性、品味、积极注意和重新评价。

关键数值与推荐

  • MORE组每日阿片剂量减少20.7%,支持性心理治疗组减少3.9%。
  • 主要结局为8个月随访期间的慢性疼痛(简明疼痛量表)和异常药物相关行为(当前阿片滥用测量量表)。
  • 阿片剂量为关键次要结局。

临床怎么用

  • MORE可作为长期阿片治疗慢性疼痛军人的心理干预选择,辅助安全阿片减量。
  • MORE在减少疼痛相关功能干扰和疼痛严重度的同时,可减少阿片剂量并改善情绪相关指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This randomized clinical trial evaluated the efficacy of Mindfulness-Oriented Recovery Enhancement (MORE) among past and present U.S. military personnel with prescriptions for long-term opioid therapy for chronic pain. METHODS: In this clinical trial, 230 past and present military personnel with prescriptions for long-term opioid therapy were randomized in a 1:1 ratio to MORE or supportive psychotherapy (initially delivered in person and then via videoconferencing after the onset of the COVID-19 pandemic). Primary outcomes were chronic pain, measured by the Brief Pain Inventory, and aberrant drug-related behaviors, measured by the Current Opioid Misuse Measure, through 8 months of follow-up. Opioid dose was a key secondary outcome. Other outcomes included psychiatric symptoms, catastrophizing, positive affect, ecological momentary assessments of opioid craving, and opioid attentional bias. RESULTS: MORE was superior to supportive psychotherapy through the 8-month follow-up in reducing pain-related functional interference, pain severity, and opioid dose. MORE reduced daily opioid dose by 20.7%, compared with a dose reduction of 3.9% with supportive psychotherapy. Although there was no overall between-group difference in opioid misuse, the in-person MORE intervention outperformed supportive psychotherapy for reducing opioid misuse. MORE reduced anhedonia, pain catastrophizing, craving, and opioid attentional bias and increased positive affect to a greater extent than supportive psychotherapy. MORE also modulated therapeutic processes, including mindful reinterpretation of pain sensations, nonreactivity, savoring, positive attention, and reappraisal. CONCLUSIONS: Among past and present U.S. military personnel, MORE led to sustained decreases in chronic pain, opioid use, craving, and opioid cue reactivity. MORE facilitated opioid dose reduction while preserving adequate pain control and preventing mood disturbances, suggesting its utility for safe opioid tapering.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Garland EL, Nakamura Y, Bryan CJ, et al. Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial. Am J Psychiatry. 2024. PMID: 38196335. doi:10.1176/appi.ajp.20230272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。